The Chimeric Antigen Receptor (CAR)-T Therapy Treatment market was valued at USD 2.44 Billion in 2024 and is expected to reach USD 6.66 Billion by 2032, growing at a CAGR of 15.3% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.